Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

E. Hanover, New Jersey 07936


Purpose:

This 10-12 week study will provide data on the safety and efficacy of using 320 valsartan and 80 mg simvastatin together compared to using either one alone in lowering blood pressure and LDL cholesterol. After discontinuing current drug therapies for hypertension and hypercholesterolemia, patients will be given 320mg valsartan+80mg simvastatin, 320mg valsartan+placebo, or 80mg simvastatin+placebo..


Criteria:

Inclusion Criteria: - ESSENTIAL HYPERTENSION - ELEVATED LDL-C CHOLESTEROL - USING STABLE DOSE OF HMG CoA REDUCTASE INHIBITOR (STATIN) FOR 3+ MONTHS Exclusion Criteria: - SEVERE HYPERTENSION - EVIDENCE OF HISTORY OR CURRENT HEART DISEASE - HISTORY OF STROKE OR MYOCARDIAL INFARCTION - DISLIPIDEMIA OR HYPERTENSION DUE TO SECONDARY CAUSES - UNCONTROLLED DIABETES OR INSULIN Other protocol-defined exclusion criteria may apply.


NCT ID:

NCT00171093


Primary Contact:

Study Director
Novartis Pharmaceuticals
Novartis Pharmaceuticals


Backup Contact:

N/A


Location Contact:

E. Hanover, New Jersey 07936
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.